Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
1.35M
-
Shares change
-
+715K
-
Total reported value, excl. options
-
$4.73M
-
Value change
-
+$2.52M
-
Number of buys
-
14
-
Number of sells
-
-8
-
Price
-
$3.53
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2020
38 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q2 2020.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.35M shares
of 41M outstanding shares and own 3.29% of the company stock.
Largest 10 shareholders include MORGAN JESS S & CO INC (413K shares), RENAISSANCE TECHNOLOGIES LLC (224K shares), Phoenix Holdings Ltd. (182K shares), ETF MANAGERS GROUP, LLC (90.8K shares), BlackRock Inc. (72K shares), Frontier Wealth Management LLC (71.9K shares), MARSHALL WACE, LLP (48.3K shares), LMR Partners LLP (33K shares), BOOTHBAY FUND MANAGEMENT, LLC (31K shares), and Virtu Financial LLC (25.7K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.